Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8446488 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
These results support the use of MSI status as a marker of prognosis and response to 5-FU-based chemotherapy in patients with colon cancers. Further study is mandatory to evaluate the precise role of MSI in patients with rectal cancers and the effect of 5-FU-based chemotherapy in MSI-H tumours.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sung Pil Hong, Byung So Min, Tae Il Kim, Jae Hee Cheon, Nam Kyu Kim, Hoguen Kim, Won Ho Kim,